论文部分内容阅读
支气管哮喘(简称哮喘)是常见的呼吸系统疾病。临床上以反复发作性喘息、气急、胸闷或咳嗽等为其主要特征。现已证实,哮喘是一种气道的慢性非特异性炎症,是由多种炎性细胞,是炎性介质和细胞因子参与的炎症过程,现就支气管哮喘的治疗近况综述如下。1支气管扩张剂:(1)肾上腺素能β2受体激动剂(β2激动剂):气雾及干粉吸入制剂常用药物有特布他林。以上药物吸入后,通常在5～10分钟起效,疗效持续约4～6小时,均属短效β2激
Bronchial asthma (asthma) is a common respiratory disease. In clinical recurrent wheezing, shortness of breath, chest tightness or cough as its main feature. Has been confirmed that asthma is an airway chronic non-specific inflammation, is a variety of inflammatory cells, inflammatory mediators and cytokines involved in the inflammatory process, the current status of the treatment of bronchial asthma are summarized below. 1 bronchodilator: (1) adrenergic β2 receptor agonist (β2 agonist): aerosol and dry powder inhalation preparations commonly used drugs terbutaline. The above drug inhalation, usually 5 to 10 minutes onset, the effect lasted about 4 to 6 hours, are short-acting β2 excitement